UPDATED: FDA Approves Quicker-Acting Malignant Hyperthermia Antidote

The FDA has approved Eagle Pharmaceutical Inc's Ryanodex (dantrolene sodium) for the treatment of malignant hyperthermia, along with the appropriate supportive measures.